Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea
Gut and Liver · 2026
DOI: 10.5009/gnl250479 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift Gut and Liver, 2026. Verfasst von Hyunjae Shin und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Antiviral Agents, Drug Substitution, Guanine, Hepatitis B, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Daewoong Pharmaceutical Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Dong-A University Hospital, Busan, Korea.
- Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
- Department of Gastroenterology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
- Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
ORCID-Profile: Hyunjae Shin, Moon Haeng Hur, Yang Hyun Baek, Chun Kyon Lee, Yong Kyun Cho, June Sung Lee, Jae Yoon Jeong, Yong Jin Jung, Ja Kyung Kim, Moon Young Kim, Yeon Seok Seo, Woo Jin Chung, Moon Soo Koh, Jeong-Han Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Förderung
- Daewoong Pharmaceutical Company
Zitieren
APA
Shin, H., Hur, M. H., Baek, Y. H., Lee, C. K., Cho, Y. K., Lee, J. S., Jeong, J. Y., Jung, Y. J., Kim, J. K., Kim, M. Y., Seo, Y. S., Chung, W. J., Koh, M. S., Kim, J. H., Lee, Y. B., Cho, E. J., Lee, J. H., Yu, S. J., Yoon, J. H., & Kim, Y. J. (2026). Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea. Gut and Liver. https://doi.org/10.5009/gnl250479
Vancouver
Shin H, Hur MH, Baek YH, Lee CK, Cho YK, Lee JS, et al. Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea. Gut and Liver. 2026. doi:10.5009/gnl250479
BibTeX
@article{Shin2026,
author = {Shin, Hyunjae and Hur, Moon Haeng and Baek, Yang Hyun and Lee, Chun Kyon and Cho, Yong Kyun and Lee, June Sung and Jeong, Jae Yoon and Jung, Yong Jin and Kim, Ja Kyung and Kim, Moon Young and Seo, Yeon Seok and Chung, Woo Jin and Koh, Moon Soo and Kim, Jeong-Han and Lee, Yun Bin and Cho, Eun Ju and Lee, Jeong-Hoon and Yu, Su Jong and Yoon, Jung-Hwan and Kim, Yoon Jun},
title = {Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea},
journal = {Gut and Liver},
year = {2026},
doi = {10.5009/gnl250479}
}
EUVIMED